Form 4: P&G Health Care CEO Boosts Stake with Stock Award

Procter & Gamble's CEO of Health Care, Jennifer L. Davis, received a significant stock award and dividend equivalent units, increasing her beneficial ownership.

Summary

• Jennifer L. Davis, CEO Health Care at Procter & Gamble Co (PG), reported changes in her beneficial ownership.
• Acquired 21,518 shares of Common Stock on August 18, 2025, as a stock award under the company's 2019 Stock and Incentive Compensation Plan.
• Acquired 24.9443 Restricted Stock Units (RSUs) on August 15, 2025, as dividend equivalents from the company's retirement program.
• Total beneficial ownership after these transactions includes 73,586.9326 shares of Common Stock held directly and 15,401.6828 shares held indirectly via a Retirement Plan Trustee.
• Total beneficial ownership of Restricted Stock Units is 228.7027 units held directly.

Sentiment

Score: 7

Explanation: The filing indicates an increase in executive ownership through compensation, which generally aligns management interests with shareholders and is a positive signal for retention and confidence, though it's not an open market purchase.

Positives

• Increased alignment of executive interests with shareholders through significant stock awards.
• The stock award of 21,518 shares and 24.9443 Restricted Stock Units demonstrates ongoing executive compensation and retention.

Negatives

• No negative information is presented in this Form 4 filing.

Risks

• No specific risks are mentioned in this Form 4 filing.

Future Outlook

Restricted Stock Units will deliver in shares upon retirement from the company, unless delivery is deferred or contributed to the reporting person's deferred compensation account.

Management Comments

• The stock award was pursuant to the issuer's 2019 Stock and Incentive Compensation Plan.
• Dividend equivalents in the form of Restricted Stock Units were previously awarded pursuant to the issuer's retirement program, representing a contingent right to receive Procter & Gamble common stock.

Industry Context

This filing reflects a routine executive compensation event within the consumer staples industry, where stock-based awards are common practice to incentivize and retain key management personnel. Such awards align executive interests with long-term shareholder value.

Comparison to Industry Standards

• Stock awards and Restricted Stock Units (RSUs) are standard components of executive compensation packages across major consumer goods companies like Unilever, Kimberly-Clark, and Colgate-Palmolive.
• The specific grant size for Jennifer L. Davis, as CEO of Health Care, is consistent with compensation structures for senior executives in large-cap companies, aiming to tie performance to equity ownership.
• While specific comparable grant sizes are not detailed in this filing, the mechanism of a $0 price stock award under an incentive plan is a widely accepted practice for executive remuneration.

Stakeholder Impact

• Shareholders: Increased alignment of executive interests with long-term shareholder value.
• Employees: Reflects standard executive compensation practices within the company.
• Executive (Jennifer L. Davis): Increased personal equity stake in the company.

Next Steps

• Restricted Stock Units will deliver in shares upon retirement from the company, unless delivery is deferred or contributed to the reporting person's deferred compensation account.

Key Dates

Keywords

Procter & Gamble, PG, SEC Form 4, Insider Trading, Stock Award, Executive Compensation, Jennifer L. Davis, Restricted Stock Units, Beneficial Ownership